MedAssets (MDAS) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Pamplona Capital Management to Acquire MedAssets
November 2, 2015 8:03 AM ESTAcquisition and realignment of MedAssets platform and planned merger with Precyse creates a national leader in end-to-end outsourced revenue cycle services, technology and education market
LONDON & NEW YORK--(BUSINESS WIRE)-- Pamplona Capital Management (Pamplona) is pleased to announce it has agreed to acquire MedAssets (NASDAQ: MDAS), a leading healthcare performance improvement company that serves four out of every five hospitals in the United States. In addition, Pamplona has entered into a separate agreement with VHA-UHC Alliance NewCo, Inc. (VHA-UHC Alliance), the nations largest member-owned healthcare company, to divest MedAssets Spend and... More
MedAssets to be Acquired by Pamplona Capital Management for $2.7 Billion
November 2, 2015 8:03 AM ESTATLANTA, Nov. 2, 2015 (GLOBE NEWSWIRE) -- MedAssets, Inc. (NASDAQ: MDAS) and Pamplona Capital Management today announced that they have entered into a definitive agreement whereby Pamplona will acquire MedAssets for $31.35 per share in cash. The purchase price represents a 44.5% premium to the 30 trading day volume weighted average price of MedAssets common stock and an enterprise value of approximately $2.7 billion.
"Since February, our executive leadership team has been developing and implementing our business transformation and value creation plan to prepare MedAssets for a growth-oriented future within a value-based healthcare world. We have been making substantial progress,... More
MedAssets Reports Third Quarter and Nine-Month 2015 Financial Results
November 2, 2015 8:01 AM ESTATLANTA, Nov. 2, 2015 (GLOBE NEWSWIRE) -- MedAssets, Inc. (NASDAQ: MDAS) today announced results for its third quarter and nine-month period ended September 30, 2015, which are summarized below.
Three-Month Period     (In millions, except per share) 3Q'15 3Q'14 % Change Net Revenue:    Spend and Clinical Resource Mgmt. (SCM) $117.2 $105.8 10.8% Revenue Cycle Management (RCM)... More